Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Translational Data Presented at EACCI Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
-
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at EACCI 2025
-
Upstream Bio Appoints Stacy Price as Chief Technology Officer
-
SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- Medical Learning Institute Inc (MLI), a non-profit jointly accredited continuing education (CE) provider, today announced the launch of reelCE™,...
-
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
-
Upstream Bio to Present at Upcoming March Investor Conferences
-
Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Upstream appoints Allison Ambrose as General Counsel
-
Upstream Bio (Nasdaq:UPB) to be added to Russell 2000® index effective at the open of the U.S. equities market on Monday, December 23.
-
Upstream Bio CEO to participate in fireside chat at Piper Sandler